Together with these findings in gastric cancer tissues, we postulate that the abnormal alternative splicing, which results in elevated OPN-a expression, may intensively occur during the progression of GC, while OPN-c may prevent adverse clinical outcomes. Here, SPP1 is linked to gastric cancer.